Skip to main content
. 2021 Feb 3;180(6):1885–1894. doi: 10.1007/s00431-021-03958-8

Fig. 1.

Fig. 1

First choice of steroid-sparing drugs for FRNS and SDNS. CNI calcineurin inhibitor, MMF mycophenolate mofetil